Emerge Medical introduces generic implants and instruments

Emerge Medical announced in a press release the introduction of a line of high-quality generic implants and instruments. Emerge Medical focuses on core devices that are easily standardized for use across multiple procedures and have low physician preference, meaning that physicians are not partial to a specific brand, according to the release.

“Our supply chain model offers hospitals and physicians high-quality products at a significantly lower cost, changing the way medical device sales are approached and empowering hospitals to improve efficiency,” said John Marotta, chief executive officer of Emerge Medical. “Emerge’s present focus is on the orthopedic trauma market, but our vision is to apply our generic device platform to the larger orthopedic, sports medicine and spine market, and ultimately to the entire $92 billion medical device industry.”

The company addresses health care costs by working directly with hospital administrators, department heads and surgeons to reduce the add-on expenses typically associated with medical device sales forces, according to the release. These factors enable Emerge Medical to transfer savings of up to 50% to its customers. All products are manufactured in the United States.